BIB Ultra Nasdaq Biotechnology Proshares
- 54.860
- -0.640-1.15%
Wall Street Today: Market Quaking With Anticipation, and Nvidia Delivers Beat
Here's How Much You Would Have Made Owning Alnylam Pharmaceuticals Stock In The Last 20 Years
Amgen Shares Snap Six Straight Sessions of Gains
10 Health Care Stocks Whale Activity In Today's Session
Live Stock News: Market Climbs Back From Tech Pit, Awaits Prodigal Semi Son to Report
AstraZeneca's Investigational Cancer Drug Shows First-Line Benefit In Combination With Widely Cancer Medicines
AstraZeneca's Camizestrant Showed Improvement in Breast Cancer Treatment During Late Stage Trial
Stock Pickers' Light Tech Holdings Are Blessing as Megacaps Fall
AstraZeneca's SERENA-6 Study Assesses Camizestrant for HR-Positive Breast Cancer, Key Outcomes Awaited
Kiniksa Issues Updates on Abiprubart, KPL-387, Mavrilimumab
Wall Street Today: All Fun and Games Until Consumers Get Uneasy
Express News | Ukraine Agrees to U.S. Mineral Deal: Financial Times
Is Vertex Pharmaceuticals Gaining or Losing Market Support?
Live Stock News: Tesla, Bitcoin, Major Mag Seven Tech Pullback
Regeneron Touts Encouraging Early Data From Investigational Gene Therapy For Rare Form Of Hearing Loss
J&J Suing Samsung Bioepis Over Stelara Biosimilar: Report
Wall Street Today: Market Had Us in the First Half, Not Gonna Lie
Regeneron Pharmaceuticals Presents Latest DB-OTO Results, Says Demonstrate Clinically Meaningful Hearing Improvements In Nearly All Children With Profound Genetic Hearing Loss In CHORD Trial; As Presented At ARO, 10 Of 11 Children With At Least One...
Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 15 Years
Gilead Sciences Unusual Options Activity